Q32 Bio (QTTB) Return on Capital Employed (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 623.00 |
| Dec 31, 2025 | 12,046.00 |
| Sep 30, 2025 | 408.00 |
| Jun 30, 2025 | -38.00 |
| Mar 31, 2025 | -862.00 |
| Dec 31, 2024 | -325.00 |
| Sep 30, 2024 | -2,258.00 |
| Jun 30, 2024 | 2,868.00 |
| Mar 31, 2024 | -2,276.00 |
| Dec 31, 2023 | -11,903.00 |
| Sep 30, 2023 | 2,694.00 |
| Jun 30, 2023 | 1,628.00 |
| Mar 31, 2023 | 1,548.00 |
| Dec 31, 2022 | 2,237.00 |
| Sep 30, 2022 | -315.00 |
| Jun 30, 2022 | 391.00 |
| Mar 31, 2022 | -1,368.00 |
| Dec 31, 2021 | 3,088.00 |
| Sep 30, 2021 | -125.00 |
| Jun 30, 2021 | 152.00 |
| Mar 31, 2021 | 1,731.00 |
| Dec 31, 2020 | -258.00 |
| Sep 30, 2020 | -492.00 |
| Jun 30, 2020 | -783.00 |
| Mar 31, 2020 | -649.00 |
| Dec 31, 2019 | -279.00 |
| Sep 30, 2019 | -96.00 |
| Jun 30, 2019 | -18.00 |
| Mar 31, 2019 | -771.00 |
| Dec 31, 2018 | -410.00 |
| Sep 30, 2018 | 206.00 |
| Jun 30, 2018 | 599.00 |